Haemonetics Reports 2nd Quarter Fiscal 2016 Revenue of $220 Million and Adjusted EPS of $0.44, Affirms Recent Full Fiscal Year Guidance
Go back to Haemonetics Reports 2nd Quarter Fiscal 2016 Revenue of $220 Million and Adjusted EPS of $0.44, Affirms Recent Full Fiscal Year Guidance| HAEMONETICS CORPORATION (NYSE: HAE) | Delayed: 107.60 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $107.60 | 52 Week High | $39.41 | |||
| Open | $108.39 | 52 Week Low | $25.98 | |||
| Day High | $109.83 | P/E | 151.55 | |||
| Day Low | $107.56 | EPS | $0.71 | |||
| Volume | 621,115 | |||||
